---
layout:     post
title:      Series Articles of Daily Translation -- 08
subtitle:   ChinaDaily-> High-tech center helps in virus fight 
date:       2020-04-07
author:     OUC_LiuX 
header-img: img/ChinaDaily-08-highTechCenter.png
catalog: true
tags:
    - Daily Translation
    - En2Zh
    - China Daily 
---

<head>
    <script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
        MathJax.Hub.Config({
            tex2jax: {
            skipTags: ['script', 'noscript', 'style', 'textarea', 'pre'],
            inlineMath: [['$','$']]
            }
        });
    </script>
</head>

> Since 29 March, 2020, I've decided to translate an English article to Chinese edition everyday, getting started with [*China Daily*](https://www.chinadaily.com.cn/).    

> This article is originated in [this page](http://www.chinadaily.com.cn/a/202004/07/WS5e8bd285a310128217284a85.html), updated on 7th Apr, 2020.  

> 本文图片摄于2019年1月21日，华北-天津天河一号国家超算中心机房。  

## （翻译）高科技中心助力抗击病毒   

在几乎全世界都在加强抗击新型冠状病毒COVID-19的同时，天津国家超级计算机中心利用尖端技术技术发挥自己的作用，随着日益增多的用户使用该计算中心的产品寻求各式各样的解决方案，该做法也得到了回报。   

超算中心主管刘广明说：“近年来我们的用户数量持续增长，这让我们对中心的发展前景看得更加积极。” 中心表示，每天大概有一千名左右的线上用户执行着八千多项任务，当前操作数量已经接近饱和点了。    

据超算中心，在三月初，他们启动了一个同时支持中英文操作语言的、由人工智能驱动的计算机断层影像(译注：一种基于X光或超声波摄像的医疗技术)扫描分析系统，用以帮助医生治疗新型冠状病毒肺炎患者。   

来自全世界五十多个研究和开发机构的数百个专家和全国三十多家医院对这个系统进行了测试和改进。    

使用位于天津滨海新区的中国天河超算中心开发的天河综合人工智能创新平台为该系统提供支持。   

天津医科大学中心医院暨研究院副主管徐波说：“该系统诊断现存冠状病毒的首次准确率得到了一线医生的赞扬。”    

为了进一步的优化和提高模型准确率与可靠性，研发团队先在三月初训练了一个全国范围的AI平台。这是一个对新冠疑似病例CT影像进行评判的有力工具。   

中心表示，发行英文版本是为了最大化平台的效力，帮助国际医学和科学研究团队。   

在过去的几个月里，超算中心和天津医科大学中心医院研究院及其他国内医院和研究所通力合作，建立了一个基于AI的辅助系统用以分析COVID-19患者的CT影像。   

参与到该项目的其他机构包括中国抗癌协会的国家肿瘤学人工智能联合会，和中国人工智能学会旗下的智慧医疗专家委员会。中国其他的超算中心也加入到了抗击COVID-19爆发的力量中。   

广州DM智能制药有限公司表示，为助力COVID-19的治疗，该公司通过位于广州的天河二号超级计算机在1000余种药品中筛选出了30种可能对新冠有疗效的药物。   

公司首席执行官谢卫东表示公司已经与超算中心合作开发了一个筛选药品和化学化合物的算法，用以研制有重要效用的药物。   

除了抗击疫情的努力外，超算中心近期还使用国家新一代超级计算机原型：天河三号，完成了一个模拟大地震的国家级高技术项目。     


## (Original article)    

At a time when almost the entire world is ramping up the fight against COVID-19, the National Supercomputer Center in Tianjin has done its part by leveraging cutting-edge technologies, and this has paid off as an increasing number of users are using the center's products for various solutions.

"Our user number has been increasing recently, which makes us more upbeat about the center's prospects," said Liu Guangming, director of the center.

The daily online users stand above 1,000, working on 8,000 projects, and the operation is nearly at the point of saturation, the center said.

According to the supercomputer center, it launched a computed tomography scan analysis system with operating language in both Chinese and English－powered by artificial intelligence－in early March, to help doctors treat patients with novel coronavirus pneumonia.

The system was tested and adopted by hundreds of experts from over 50 research and development institutions worldwide, and from over 30 hospitals across the nation.

It is based on the Tianhe Integrated Artificial Intelligence Innovation Platform developed using China's Tianhe supercomputer at the center in Tianjin's Binhai New Area.

"The first-time accuracy of the system in confirming the presence of the coronavirus has been praised by front-line doctors," said Xu Bo, vice-director of the Tianjin Medical University Cancer Hospital and Institute.

The research and development team carried out training for the AI system nationwide in early March in a bid to further optimize and improve its accuracy and reliability. It is a powerful tool in evaluating CT images of suspected cases of the disease.

The launch of the English version aims to maximize the effectiveness of the platform and help international medical and scientific research teams, the center said.

The center teamed up with the Tianjin Medical University Cancer Hospital and Institute and other domestic hospitals and institutions to build an AI-supported assistance system over the past few months to analyze CT images of COVID-19 patients.

Other institutions involved in the project include the National Society of Artificial Intelligence in Oncology－part of the China Anti-Cancer Association－and the Professional Committee of Smart Medicine under the Chinese Association for Artificial Intelligence.

Other supercomputer centers in China have also joined forces in combating the COVID-19 outbreak.

In Guangzhou, DM Intelligence Pharm Co Ltd said the company has selected some 30 potential medications among 1,000 drugs through the Tianhe-2 supercomputer based in the city in a bid to help to treat COVID-19.

Company CEO Xie Weidong said the firm has teamed up with the supercomputer center to develop an algorithm to screen drugs and chemical compounds to develop medications with significant effect.

Apart from the center's efforts to fight against the outbreak, the center also completed a national-level high-tech project on a large earthquake simulation recently, using the prototype of the nation's new-generation supercomputer Tianhe-3.